2019
DOI: 10.1016/j.bbrc.2019.08.080
|View full text |Cite
|
Sign up to set email alerts
|

Dopamine D4 receptor protected against hyperglycemia-induced endothelial dysfunction via PI3K /eNOS pathway

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
5
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 36 publications
0
5
0
Order By: Relevance
“…The DA-induced suppression of NF-κΒ and STAT3 activity is not specific only to endothelial cells, as it has also been demonstrated in other cells, including chondrocytes, glioma cells, and hepatocytes [ 96 , 97 , 98 ]. Moreover, the protective effects of DA on endothelial cells might also include other mechanisms that were not tested in this study, but were reported previously, such as inhibition of apoptosis, oxidative stress [ 99 , 100 ], VEGF receptor 2, focal adhesion kinase, and MAPK in endothelial cells [ 101 ], as well as suppression of microvascular hyperpermeability, angiogenesis, proliferation, and migration of endothelial cells [ 102 ].…”
Section: Discussionmentioning
confidence: 87%
“…The DA-induced suppression of NF-κΒ and STAT3 activity is not specific only to endothelial cells, as it has also been demonstrated in other cells, including chondrocytes, glioma cells, and hepatocytes [ 96 , 97 , 98 ]. Moreover, the protective effects of DA on endothelial cells might also include other mechanisms that were not tested in this study, but were reported previously, such as inhibition of apoptosis, oxidative stress [ 99 , 100 ], VEGF receptor 2, focal adhesion kinase, and MAPK in endothelial cells [ 101 ], as well as suppression of microvascular hyperpermeability, angiogenesis, proliferation, and migration of endothelial cells [ 102 ].…”
Section: Discussionmentioning
confidence: 87%
“…Dopaminergic pathways are one of the regulators of autoimmune reactions [7] , with D2-like receptors playing a role in diabetes [22] . Therefore, we have investigated the association between the −521C>T DRD4 gene polymorphism and the risk of DM1 and its comorbidities.…”
Section: Discussionmentioning
confidence: 99%
“…Haloperidol, a D2 receptor antagonist, prevented this effect. Wang et al [ 59 ] reported that the protective effect of DA against endothelial dysfunction was also mediated through D4 receptors. Clinical and experimental studies showed that DA could directly increase basal local CBF, and this increase is blocked by haloperidol [ 29 , 60 , 61 ].…”
Section: Discussionmentioning
confidence: 99%